{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:13:09Z","timestamp":1791951189146,"version":"4.3.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI104681"],"award-info":[{"award-number":["UM1AI104681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24-AI093969"],"award-info":[{"award-number":["K24-AI093969"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI149026"],"award-info":[{"award-number":["R21AI149026"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Among patients with methicillin-resistant Staphylococcus aureus bacteremia, vancomycin-associated acute kidney injury increased as a function of the day 2 area under the curve (AUC), even for daily AUCs within the recommended therapeutic range (400\u2013600). Further data are needed to determine if daily AUCs &amp;lt;400 can be maintained without compromising efficacy.<\/jats:p>","DOI":"10.1093\/ofid\/ofab651","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T12:52:41Z","timestamp":1642855961000},"source":"Crossref","is-referenced-by-count":14,"title":["Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant\n                    <i>Staphylococcus aureus<\/i>\n                    Bloodstream Infections"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-0655","authenticated-orcid":false,"given":"Thomas P","family":"Lodise","sequence":"first","affiliation":[{"name":"Albany College of Pharmacy and Health Sciences, Albany, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-6130","authenticated-orcid":false,"given":"Marc","family":"Scheetz","sequence":"additional","affiliation":[{"name":"Midwestern University Chicago College of Pharmacy, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9272-6973","authenticated-orcid":false,"given":"Joseph J","family":"Carreno","sequence":"additional","affiliation":[{"name":"Albany College of Pharmacy and Health Sciences, Albany, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Chambers","sequence":"additional","affiliation":[{"name":"San Francisco General Hospital, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Vance","family":"Fowler","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina, USA"},{"name":"Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Holland","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina, USA"},{"name":"Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"key":"2022012217523390500_CIT0001","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"2022012217523390500_CIT0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.","volume":"49","author":"Lodise","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2022012217523390500_CIT0003","doi-asserted-by":"crossref","first-page":"ofaa538","DOI":"10.1093\/ofid\/ofaa538","article-title":"Vancomycin exposure and acute kidney injury outcome: a snapshot from the CAMERA2 study.","volume":"7","author":"Liu","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2022012217523390500_CIT0004","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/cid\/ciz460","article-title":"The emperor\u2019s new clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with methicillin-resistant Staphylococcus aureus bloodstream infections (PROVIDE).","volume":"70","author":"Lodise","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022012217523390500_CIT0005","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/jac\/dkz167","article-title":"Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.","volume":"74","author":"Avedissian","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022012217523390500_CIT0006","doi-asserted-by":"crossref","first-page":"e02535-16","DOI":"10.1128\/AAC.02535-16","article-title":"Establishment of an AUC0-24 threshold for nephrotoxicity is a step towards individualized vancomycin dosing for methicillin-resistant Staphylococcus aureus bacteremia.","volume":"61","author":"Chavada","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012217523390500_CIT0007","volume-title":"Renal function tests","author":"Gounden","year":"2021"},{"key":"2022012217523390500_CIT0008","volume-title":"Guidance for industry: pharmacokinetics in patients with impaired renal function\u2014study design, data analysis, and impact on dosing and labeling","author":"US Food and Drug Administration.","year":"1998."},{"key":"2022012217523390500_CIT0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01653-13","article-title":"Are vancomycin trough concentrations adequate for optimal dosing?","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012217523390500_CIT0010","volume-title":"ADAPT 5 user\\'s guide: pharmacokinetic\/pharmacodynamic systems analysis software.","author":"D\\'Argenio","year":"2009"},{"key":"2022012217523390500_CIT0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2011.32","article-title":"Section 2: AKI definition.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"2022012217523390500_CIT0012","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"2022012217523390500_CIT0013","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"2022012217523390500_CIT0014","doi-asserted-by":"crossref","first-page":"e01684-17","DOI":"10.1128\/AAC.01684-17","article-title":"Identification of vancomycin exposure-toxicity thresholds in hospitalized patients receiving intravenous vancomycin.","volume":"62","author":"Zasowski","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012217523390500_CIT0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000343162","article-title":"Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant Staphylococcus aureus pneumonia.","volume":"58","author":"Suzuki","year":"2012","journal-title":"Chemotherapy"},{"key":"2022012217523390500_CIT0016","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis.","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022012217523390500_CIT0017","doi-asserted-by":"crossref","first-page":"e01602-17","DOI":"10.1128\/AAC.01602-17","article-title":"Pharmacokinetic\/pharmacodynamic determinants of vancomycin efficacy in enterococcal bacteremia.","volume":"62","author":"Jumah","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012217523390500_CIT0018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-021-05858-6","article-title":"The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.","volume":"21","author":"Tsutsuura","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2022012217523390500_CIT0019","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/cid\/ciaa1744","article-title":"Vancomycin area under the curve-guided dosing and monitoring for adult and pediatric patients with suspected or documented serious methicillin-resistant Staphylococcus aureus infections: putting the safety of our patients first.","volume":"72","author":"Lodise","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022012217523390500_CIT0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/2\/ofab651\/42261084\/ofab651.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/2\/ofab651\/42261084\/ofab651.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T12:52:56Z","timestamp":1642855976000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab651\/6514149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab651","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2022,1,22]]},"article-number":"ofab651"}}